Mim Habits is a FoodTech company that has created a new food category (Advance Immunity Food) combining science and tradition to create foods with advanced properties that can fight ailments such as anxiety, insomnia, stress, joint pain, digestive disorders and many more, all with quality ingredients and excellent taste. 

Did you know that only 3% of your DNA is actually yours, and that the other 97% belongs to the nearly 2kg of bacteria that live in your body in perfect symbiosis, and in a 10:1 ratio with your cells? thus constituting your microbiome, your army against inflammatory diseases such as cancer, obesity, diabetes, autism or IBD (a generic term used to refer to conditions including Crohn's disease, ulcerative colitis and other inflammatory diseases affecting the intestine) among many others suffered by 1/5 people globally, as explained in the "value proposition" section. The study of the microbiome is now the No. 1 focus of research and development by laboratories such as Johnson & Johnson, Merck Sharp & Dohme, Pfizer and many others, along with numerous biotech companies, which continue to delve into what, according to Forbes, is the decade of the microbiome.

Mim Habits was founded in June 2019, after the entry of its partners, Xavi Cortadellas, Pol Tusquets and Quim Lorente, as investors in an international biotech that, after more than 10 years of research in the Human Microbiome, had developed a formula against cancer, already in phase II and with more than 90% effectiveness. 

The Mim team, after seeing that this formula, formed by bacteria, was able to have this effect on cancer patients, wanted to bring this science to food by creating universal foods with advanced properties that will improve the quality of life of any person, simply by enjoying a meal, breakfast or mid-morning snack.

In this way they started to develop, in collaboration with this biotech and using the same technology, new formulas for other ailments such as insomnia, joint pain, anxiety, digestive disorders and other conditions suffered by more than 3.5 billion people on our planet. Along the way they discovered that, thanks to the biotech's patented technology, they were able to subject bacteria to high temperatures without affecting their properties (something never seen before) so they were able to make bread, chocolate and any food that requires temperature for its elaboration, allowing them to be pioneers and create for the first time a range of foods with advanced properties. Today they already have 8 SKUs (Stock Keeping Unit or versions) in the market, 4 breads for different ailments that you can find with or without gluten, in Spain 10 days ago in their own ecommerce and soon in physical point of sale and in the UK in October 2022 through their ecommerce and Amazon.

Of these 8 SKUs, they have 4 formulas under an exclusive contract with this biotech (under a 4% royalty), which allows them to exploit it in food and 4 new formulas (for psoriasis, joint pain, fertility and cholesterol for the next 6 months) under development, owned by Mim Habits. 

They aim to become the dominant player in this category and will do so by reaching 9 markets, including the US, UK and Australia (leading supplement markets along with China and Russia) by creating 30 new Mim Habits proprietary formulas/patents and a total of 60 products.